These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24567169)

  • 1. Optimization of an amplification protocol for misfolded proteins by using relaxed control.
    Coron JM; Gabriel P; Shang P
    J Math Biol; 2015 Jan; 70(1-2):289-327. PubMed ID: 24567169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalizing a mathematical model of prion aggregation allows strain coexistence and co-stability by including a novel misfolded species.
    Lemarre P; Pujo-Menjouet L; Sindi SS
    J Math Biol; 2019 Jan; 78(1-2):465-495. PubMed ID: 30116882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
    Moreno-Gonzalez I; Soto C
    Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion-like features of misfolded Aβ and tau aggregates.
    Morales R; Callegari K; Soto C
    Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases.
    Schmitz M; Cramm M; Llorens F; Müller-Cramm D; Collins S; Atarashi R; Satoh K; Orrù CD; Groveman BR; Zafar S; Schulz-Schaeffer WJ; Caughey B; Zerr I
    Nat Protoc; 2016 Nov; 11(11):2233-2242. PubMed ID: 27735933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-molecule approaches to prion protein misfolding.
    Yu H; Dee DR; Woodside MT
    Prion; 2013; 7(2):140-6. PubMed ID: 23357831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free amplification of prions: Where do we stand?
    Cazzaniga FA; De Luca CMG; Bistaffa E; Consonni A; Legname G; Giaccone G; Moda F
    Prog Mol Biol Transl Sci; 2020; 175():325-358. PubMed ID: 32958239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of prions in vitro and the protein-only hypothesis.
    Diaz-Espinoza R; Soto C
    Prion; 2010; 4(2):53-9. PubMed ID: 20448454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prions and the potential transmissibility of protein misfolding diseases.
    Kraus A; Groveman BR; Caughey B
    Annu Rev Microbiol; 2013; 67():543-64. PubMed ID: 23808331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion seeded conversion and amplification assays.
    Orrú CD; Caughey B
    Top Curr Chem; 2011; 305():121-33. PubMed ID: 21678135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplified Detection of Prions and Other Amyloids by RT-QuIC in Diagnostics and the Evaluation of Therapeutics and Disinfectants.
    Caughey B; Orru CD; Groveman BR; Hughson AG; Manca M; Raymond LD; Raymond GJ; Race B; Saijo E; Kraus A
    Prog Mol Biol Transl Sci; 2017; 150():375-388. PubMed ID: 28838670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A universal method for detection of amyloidogenic misfolded proteins.
    Yam AY; Wang X; Gao CM; Connolly MD; Zuckermann RN; Bleu T; Hall J; Fedynyshyn JP; Allauzen S; Peretz D; Salisbury CM
    Biochemistry; 2011 May; 50(20):4322-9. PubMed ID: 21539296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Misfolding Cyclic Amplification of Infectious Prions.
    Moda F
    Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion proteins.
    Tatzelt J
    Top Curr Chem; 2011; 305():ix-x. PubMed ID: 22049556
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays.
    Manca M; Kraus A
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32854212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insight into the antiprion compound inhibition mechanism of native prion folding over misfolding.
    Choi J; Govindaraj RG; Hyeon JW; Lee K; Ma S; Kim SY; Lee J; No KT
    Chem Biol Drug Des; 2017 Jun; 89(6):907-917. PubMed ID: 27933736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding prion structure and conversion.
    Spagnolli G; Requena JR; Biasini E
    Prog Mol Biol Transl Sci; 2020; 175():19-30. PubMed ID: 32958233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.